Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28552404 | 0.86 | SLC29A1 (0.51) | SLC29A1ADORA2AADORA2BADORA3DOT1L | |
| SCHEMBL2583651 | 0.75 | SLC29A1 (0.52) | SLC29A1HIF1AADORA2AADORA2BBCHE | |
| SCHEMBL12174032 | 0.75 | SLC29A1 (0.52) | SLC29A1HIF1AADORA2AADORA2BBCHE | |
| SCHEMBL23982354 | 0.75 | SLC29A1 (0.52) | SLC29A1HIF1AADORA2AADORA2BBCHE | |
| SCHEMBL2585394 | 0.75 | SLC29A1 (0.52) | SLC29A1HIF1AADORA2AADORA2BBCHE | |
| SCHEMBL23982564 | 0.75 | SLC29A1 (0.52) | SLC29A1HIF1AADORA2AADORA2BBCHE | |
| SCHEMBL29884287 | 0.74 | ADORA2A (0.44) | SLC29A1ADORA2AADORA2BADORA3DOT1L | |
| SCHEMBL30324459 | 0.73 | ADORA3 (0.54) | SLC29A1ADORA2AADORA2BADORA3DOT1L | |
| SCHEMBL30324473 | 0.73 | ADORA1 (0.55) | SLC29A1HIF1AADORA2AADORA2BADORA3 | |
| SCHEMBL3039007 | 0.70 | SLC29A1 (0.55) | SLC29A1HIF1AADORA2AADORA2BBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112714649-A | Novel cyclic dinucleotide derivatives and antibody drug conjugates thereof | 第一三共株式会社 | 2021-04-27 | — | — | CN | disclosed |